{{Rsnum
|rsid=2297440
|Gene=RTEL1
|Chromosome=20
|position=63680946
|Orientation=plus
|GMAF=0.3113
|Gene_s=PLEKHJ1,RTEL1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 54.2 | 42.1 | 3.7
| HCB | 11.2 | 34.3 | 54.5
| JPT | 9.8 | 42.9 | 47.3
| YRI | 96.4 | 3.6 | 0.0
| ASW | 80.4 | 17.9 | 1.8
| CHB | 11.2 | 34.3 | 54.5
| CHD | 8.3 | 34.9 | 56.9
| GIH | 63.5 | 33.3 | 3.1
| LWK | 94.4 | 5.6 | 0.0
| MEX | 66.7 | 22.8 | 10.5
| MKK | 90.1 | 9.9 | 0.0
| TSI | 62.9 | 30.9 | 6.2
| HapMapRevision=28
}}{{PMID Auto
|PMID=23683922
|Title=RTEL1 tagging SNPs and haplotypes were associated with glioma development
|OA=1
}}

{{PMID Auto
|PMID=20368557
|Title=Polymorphisms of LIG4, BTBD2, HMGA2, and RTEL1 genes involved in the double-strand break repair pathway predict glioblastoma survival.
|OA=1
}}

{{PMID Auto
|PMID=21356187
|Title=Distinct germ line polymorphisms underlie glioma morphologic heterogeneity.
|OA=1
}}

{{PMID Auto
|PMID=23812731
|Title=RTEL1 and TERT polymorphisms are associated with astrocytoma risk in the Chinese Han population.
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}